Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Takara Bio Inc.

Clinical trials sponsored by Takara Bio Inc., explained in plain language.

Takara Bio Inc. 4974 TOKYO

Biotech company providing life science research tools and gene therapy services.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1

Engineered immune cells take on rare sarcoma in early trial

Disease control Recruiting now

This study tests a personalized cell therapy called TBI-1301 for people with a rare soft-tissue cancer called synovial sarcoma that has spread or come back. The therapy uses a patient's own immune cells, modified to attack cancer cells with a specific marker (NY-ESO-1). About 5 a…

Phase: PHASE3 • Sponsor: Takara Bio Inc. • Aim: Disease control

Last updated Jun 27, 2026 09:06 UTC